Table 6.
Summary of clinical literatures on autologous platelet concentrate for spinal fusion
Ref. | Description of study | |
---|---|---|
Lumbar spine | ||
Hee et al. [40] | A prospective study of AGF in instrumented transforaminal lumbar interbody spinal fusion | |
Lowery et al. [57] | Retrospective case series using autologous growth factor concentrate in lumbar posterolateral spinal fusion | |
Weiner et al. [103] | Retrospective review of an autograft alone and an autograft with AGF in posterolateral spinal fusion | |
Carreon et al. [23] | Retrospective review of platelet gel in instrumented posterolateral spinal fusion |
Ref. | Evidence level | Conclusion |
---|---|---|
Lumbar spine | ||
Hee et al. [40] | II | The use of AGF in TLIF procedures did not increase the overall fusion rates; however, it might promote a faster rate of fusion |
Lowery et al. [57] | IV | AGF may enhance the formation of new bone in lumbar spinal fusion when used in combination with autografts |
Weiner et al. [103] | III | The use of AGF resulted in inferior rates of fusion compared with those of autograft alone |
Carreon et al. [23] | III | Platelet gel failed to enhance the fusion rate when added to autograft |